Germline BRCA2 status may be linked to PCa outcomes: Outcomes linked with mutation may be modified by initial Tx approach.

Detalles Bibliográficos
Publicado en:Urology Times Vol. 47; no. 3; p. 9
Autor principal: Schieszer, John
Formato: brief item Journal Article
Publicado: MJH Life Sciences Mar2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=135201222&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 135201222
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: Mar2019
      vid: 47
      iid: 3
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        135201222
        135201222
        135201222
        135201222
      ppf: 9
      ppct: 0
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Germline BRCA2 status may be linked to PCa outcomes: Outcomes linked with mutation may be modified by initial Tx approach.
      aug:
        au: Schieszer, John
      sug:
        subj:
          Genes, BRCA
          Mutation
          Prostatic Neoplasms, Castration-Resistant Familial and Genetic
          Prostatic Neoplasms, Castration-Resistant Therapy
      pubtype: Academic Journal
      doctype:
        brief item
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N